Nurse Practitioner in Juneau, WI Accepting Medicare
3 Nurse Practitioner nurses found. Showing 1 - 3
 Amanda M Reda-goglio, APNP Nurse Practitioner - Psych/Mental Health Medicare: May Accept Medicare Assignments Practice Location: 199 County Road Df, Juneau, WI 53039 Phone: 920-386-3492 |
Kristine Marie Gay, APNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 334 S Western Ave, Juneau, WI 53039 Phone: 902-386-0290 |
Dana Marie Stinnett, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 334 S Western Ave, Juneau, WI 53039 Phone: 920-386-0290 Fax: 920-386-0288 |
News Archive
Study: Preoperative interventions improve outcomes of patients undergoing CABG surgery
A quality improvement initiative improved the outcomes of patients undergoing cardiac surgery at select medical centers in northern New England, according to a study in the December issue of Critical Care Nurse (CCN).
Scientists discover a method to detect trace levels of swine antibiotics in the groundwater.
Scientists from the Department of Soil, Water, & Climate at University of Minnesota have developed a simple method to quantify two types of antibiotics in animal manures, and surface and ground waters. Chlortetracycline and tylosin antibiotics are commonly used for growth promotion in swine production.
AstraZeneca first quarter revenue down 11% to $7,349 million
First quarter results reflect challenging revenue picture. Pipeline strengthened by Amgen collaboration, the agreement to acquire Ardea Biosciences and positive CHMP opinion for FORXIGATM (dapagliflozin) in Europe.
Moores Cancer Center files IND application for topical NexACT-based formulation
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Moores Cancer Center at the University of California San Diego (UCSD) has filed an Investigational New Drug Application with the U.S. Food & Drug Administration ("FDA") for approval to test Nupen, Apricus Bio's proprietary, topical NexACT-based formulation of filgrastim (Neupogen).
Expert offers COVID-19 guidance for patients with COPD
Chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema, is a chronic lung disease that makes it hard to breathe. The disease affects millions of Americans and is the fourth leading cause of disease-related death in the U.S. People with COPD have a higher risk of more severe illness from COVID-19 due to their existing lung problems.
› Verified 1 days ago